PEST-dependent cytoplasmic retention of v-Rel by IκB-α: Evidence that IκB-α regulates cellular localization of c-Rel and v-Rel by distinct mechanisms

Journal of Virology

Volumn 70, Issue 5, 1996, Pages 3176-3188

  Rottjakob, Elizabeth M ^a,b   Sachdev, Shrikesh ^a   Leanna, Candice A ^a   McKinsey, Timothy A ^a,c   Hannink, Mark ^a  

^a University of Missouri   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ARTICLE; CARCINOGENICITY; CELLULAR DISTRIBUTION; CYTOPLASM; DNA BINDING; NONHUMAN; ONCOVIRINAE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION;

EID: 0029916228     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.5.3176-3188.1996     Document Type: Article

References (52)

1. Adams, S. A., R. Sterne-Marr, and L. Gerace. 1990. Nuclear import in permeabilized mammalian cells requires soluble cytoplasmic factors. J. Cell Biol. 111:807-816.
2. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev Immunol. 120:141-179.
3. Beg, A. A., S. M. Ruben, R. I. Scheinman, S. Haskill, C. A. Rosen, and A. S. Baldwin, Jr. 1992. IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention Genes Dev. 6:1899-1913.
4. Bressler, P., K. Brown, W. Timmer, V. Bours, U. Siebenlist, and A. S. Fauci. 1993. Mutational analysis of the p50 subunit of NF-κB and inhibition of NF-κB activity by trans-dominant mutants. J. Virol. 67:288-293.
5. Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB. Proc. Natl. Acad. Sci. USA 90:2532-2536.
6. c-rel is a cytoplasmic protein in chicken embryo fibroblasts, Oncogene 5:257-266.
7. Chang, C.-C., J. Zhang, L. Lombardi, A. Neri, and R. Dalla-Favera. 1995. Rearranged NFKB2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators. Mol. Cell. Biol. 15:5180-5187.
8. Conover, W. J. 1971. Practical nonparametric statistics. John Wiley and Sons, New York,
9. Davis, N., S. Ghosh, D. L. Simmons, P. Tempst, H. C. Lion, D. Baltimore, and H. R. Bose, Jr. 1991. Rel-associated pp40: an inhibitor of the Rel family of transcription factors. Science 253:1268-1271.
10. IκB-β inhibition of DNA binding by rel proteins. Mol. Cell. Biol. 13:1769-1778.
11. Ernst, M. K., L. L. Dunn, and N. R. Rice. 1995. The PEST-like sequence of IκB-α is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers. Mol. Cell Biol. 15:872-883
12. Fields, S., and O. Song. 1989. A novel genetic system to detect protein-proiein interactions. Nature (London) 340:245-246.
13. Gauchi, P. A., S. C. Sun, W. C. Greene, and D. W. Ballard. 1992. IκB-α/ MAD-3 masks the nuclear localization signal of NF-κB p65 and requires the transactivation domain to inhibit NF-κB p65 DNA binding. Mol. Biol. Cell 3:1339-1352
14. Ghosh, G., G. Van Duyne, S. Gbosh, and P. B. Sigler. 1995. Structure of NF-κB p50 homodimer bound to a κB site. Nature (London) 373:303-310.
15. Gilmore, T. D. 1995. Regulation of Rel transcription complexes, p. 104-133 In S. Goodburn (ed.). Frontiers in molecular biology: eukaryotic gene transcription. Oxford University Press. Oxford.
16. Gilmore, T. D., and H. M. Temin. 1988. v-Rel oncoproteins in the nucleus and in the cytoplasm transform chicken spleen cells. J. Virol. 62:703-714.
17. Hannink, M., and H, M. Temin. 1989. Transactivation of gene expression by nuclear and cytoplasmic rel proteins. Mol. Cell. Biol 9:4323-4336.
18. Henkel, T.. T. Machleidt, I. Alkalay, M. Kronke, Y. Ben-Neriah, and P. A. Bauerle. 1993. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB. Nature (London) 365:182-185.
19. Hrdlickova, R., J. Nehyba, and E. H. Humphries. 1994. In vivo evolution of c-Rel oncogenic potential. J. Virol. 68:2371-2382.
20. Hrdlickova, R., J. Nehyba, and E. H. Humphries. 1994. v-Rel induces expression of three avian immunoregulatory surface receptors more efficiently than c-Rel. J. Virol. 68:308-319.
21. Hrdlickova, R., J. Nehyba, A. Roy, E. H. Humphries, and H. R. Bose, Jr. 1995. The relocalization of v-Rel from the nucleus to the cytoplasm coincides with induction of expression of Ikbα and nfκb1 and stabilization of IκB-α. J. Virol. 69:403-413.
22. Inoue, J., L. D. Kerr, D. Rashid, N. Davis, H. R. Bose, Jr., and I. M. Verma. 1992. Direct association of pp40/IκB-β with Rel/NF-κB transcription factors: role of ankyrin repeats in the inhibition of DNA-binding activity. Proc. Natl. Acad. Sci USA 89:4333-4337.
23. Inoue, J. I., L. D. Kerr, L. J. Ransome, E. Bengal, T. Hunter, and I. M. Verma. 1991. c-Rel activates but v-Rel represses transcription from κB sites. Proc. Natl. Acad. Sci USA 883715-3719.
24. Ishikawa, H., M. Asano, T. Kanda, S. Kumar, C. Gelinas, and Y. Ito. 1993. Two novel functions associated with the Rel oncoproteins: DNA replication and cell-specific transcriptional activation. Oncogene 8:2889-2896.
25. Kamens, S., P. Richardson, G. Mosialos, R. Brent, and T. D. Gilmore. 1990. Oncosenic transformation by v-Rel requires an amino-terminal activation domain. Mol. Cell Biol. 10:2840-2847.
26. Kralova, J., J. D. Schatzte, W. Bargmann, and H. R. Bose, Jr. 1994. Transformation of avian fibroblasts overexpressing the c-Rel proto-oncogene and a variant of c-Rel lacking 40 C-terminal amino acids. J. Virol. 68:2071-2083.
27. Kumar, S., and C. Gelinas. 1993. IκB-α-mediated inhibition of v-Rel DNA-binding requires direct interaction with the RxxRxRxxC Rel/κB DNA-binding motif. Proc Natl. Acad Sci. USA 90:8962-8966.
28. Kumar, S., A. B. Rabson, and C. Gelinas. 1992. The RxxRxRxxC motif conserved in all Rel/κB proteins is essential for the DNA-binding activity and redox regulation of the v-Rel protein. Mol Cell. Biol 12:3094-3106.
29. Lu, D., J. D. Thompson, G. K. Gorski, N. R. Rice, M. G. Mayer, and J. J. Yunis. 1991. Alterations at the rel locus in human lymphoma. Oncogene 6:1235-1241.
30. Mellitis, K. H., R. T. Hays, and S. Goodbourn. 1993. Proteolytic degradation of MAD3(IκB-α) and enhanced processing of NF-κB precursor p105 are obligatory steps in the activation of NF-κB. Nucleic Acids Res. 21:5059-5066.
31. Morrison, L. E., G. Boehmelt, and P. J. Enrietto. 1992. Mutations in the Rel-homology domain alter the biochemical properties of v-Rel and render it transformation defective in chicken embryo fibroblasts Oncogene 7:1137-1147.
32. Mosialos, G., and T. D. Gilmore. 1992. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition site Oncogene 8:723-730.
33. c-rel. Mol. Cell. Biol. 11:5867-5877.
34. Muller, C. W., F. A. Rey, M. Sodeoka, G. L. Verdine, and S. C. Harrison. 1995. Structure of the NF-κB p50 homodimer bound to DNA. Nature (London) 373:311-317.
35. Nehyba, J., R. Hrdlickova, and E. H. Humphries. 1994. Evolution of the oncogenic potential of v-Rel. Rel-induced expression of immunoregulatory receptors correlates with tumor development and in vitro transformation. J. Virol. 68:2039-2050.
36. Ohno, H., G. Takimoto, and T. W. McKeithan. 1990. The candidate protooncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60:991-997.
37. Rice, N. R., and M. K. Ernst. 1993. In vivo control of NF-κB activation by IκB-α. EMBO J. 12:4685-4695
38. Richardson, P. M., and T. D. Gilmore. 1991 v-Rel is an activate member of the Rel family of transcriptional activating proteins. J. Virol. 65:3122-3130.
39. Ryseck, R.-P., P. Bull, M. Takamiay, V. Bours, U. Siebenlist, P. Dobrzanski, and R. Bravo. 1992. RelB, a new Rel family transcriptional activator that can interact with p50-NF-κB. Mol. Cell. Biol l2:674-684.
40. 39a.Sachdev, S., and M. Hannink. Unpublished results
41. Sachdev, S., E. M. Rottjakob, J. Alan Diehl, and M. Hannink. 1995. IκB-α mediated inhibition of nuclear transport and DNA-binding by Rel proteins are separable functions: phosphorylation of C-terminal serine residues of IκB-α is specifically required for inhibition of DNA-binding. Oncogene 11: 811-823.
42. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning, a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
43. Schiestl, R. H., and R. D. Gietz. 1989 High efficiency transformation of intact yeast cells using single-stranded DNA as carrier. Curr. Genet 16:339-346.
44. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10:405-455.
45. Smardova, J., A. Walker, L. E. Morrison, N. Kabrun, and P. J. Enrietto. 1995 The role of the carboxy-terminus of v-Rel in transformation and activation of endogenous gene expression. Oncogene 10:2017-2026.
46. Steward, R., and S. Govind. 1993. Dorsai-ventral polairty in the Drosophila embryo. Curr. Opin. Genet, Dev. 3:556-561.
47. Sun, S. C., P. A. Gandhi, D. W. Ballard, and W. C. Greene. 1993 NF-κB controls expression of inhibitor κB-α: evidence for an induable autoregulatory pathway. Science 259:1912-1915
48. Walker, W. H., B. Stein, P. A. Ganchi. J. A. Hoffiman, P. A. Kaufman, D. W. Ballard, M. Hannink, and W. C. Greene. 1992, The v-Rel oncogene: jnsights into the mechanism of transcriptional activation, repression and transformation. J. Virol. 66:5018-5029.
49. Wen, W., J. L. Meinkoth, R. Y. Tsien, and S. S. Taylor. 1995, identification of a signal for rapid export of proteins from the nucleus. Cell 82:463-473.
50. Wilhelmsen, K. C., K. Eggleton, and H. M. Temin. 1984. Nucleic acid sequences of the oncogene v-Rel in reticuloendothcliosis virus strain T and its cellular homolog, the protooncogene c-Rel. J. Virol. 52:172-182.
51. Xu, X., C. Prorock, H. Ishikawa, E. Maldonado, V. Ito, and C. Gelinas. 1993. Functional interaction of the v-Rel and c-Rel oncoproteins with the TATA-binding protein and association with transcription factor IIB. Mol Cell Biol. 13:6733-6741.
52. Zabel, U., T. Henkel, M. S. Suva, and P. A. Bauerle. 1993. Nuclear uptake control of NF-κB by MAD-3, an IκB protein present in the nucleus EMBO J 12:201-211.